Company Canopus BioPharma Incorporated

Equities

Market Closed - OTC Markets Other stock markets 20:58:53 07/06/2024 BST			5-day change	1st Jan Change
0.0003 ^USD	0.00%		-25.00%	-25.00%

2023	Canopus Biopharma Inc. Announces Amendment to its Original Distributor Partnership Beverage Agreement with PepsiCo, Inc	CI
2023	Canopus BioPharma Incorporated announced that it expects to receive $1 million in funding	CI

Managers	Title	Age	Since
Benjamin Oates CEO	Chief Executive Officer	-	16/02/22

Members of the board	Title	Age	Since
Benjamin Oates CEO	Chief Executive Officer	-	16/02/22

Name	Equities	%	Valuation
Mango Innovation LLC 3.437 %	80,000,000	3.437 %	40 000 $

Canopus Biopharma, Inc.

26 South Rio Grande Street Suite 2072

84043, Salt Lake City

This company's sector is not yet available